Results 81 to 90 of about 11,291,129 (270)

Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis [PDF]

, 2009
This is an electronic version of an article published in Amyloid 2009, Vol. 16, No. 3 : Pages 183-185. Amyloid is available online at: http://informahealthcare.com/doi/pdf/10.1080/13506120903151825A male patient with primary AL amyloidosis who had been ...
Tazawa, Ko-Ichi, Ikeda, Shu-ichi, Matsuda, Masayuki, Shimojima, Yasuhiro, Katoh, Nagaaki   +4 more
core   +1 more source

Regimens used for AL amyloidosis patients per line of treatment.

, 2022
Regimens used for AL amyloidosis patients per line of treatment.
Patricia Sorroche (14020175), Elsa Mercedes Nucifora (14020178), Maria Lourdes Posadas-Martinez (14020163), María Adela Aguirre (14020166), Erika Brulc (14020169), Mariana Fernandez (8904974), Gerardo Machnicki (52539), Maria Soledad Saez (14020172)   +7 more
core   +1 more source

Safety outcomes of antidiabetic medications: A comprehensive review of the EU summaries of product characteristics and international clinical practice guidelines

British Journal of Clinical Pharmacology, EarlyView.
Aims Information on the safety profile of antidiabetic medications is essential for informed treatment decisions in type 2 diabetes mellitus. Although this information is available in regulatory documents of individual drugs, a comprehensive overview across all approved antidiabetics is lacking.
David Liang, Daniala L. Weir, Safana Thevasahayam, Vera H. M. Deneer, Arno Siebes, Helga Gardarsdottir   +5 more
wiley   +1 more source

A Case of Systemic AL Amyloidosis Diagnosed by Screening Colonoscopy

Case Reports in Gastrointestinal Medicine, 2022
Amyloidosis encompasses several diseases associated with deposition of low-molecular-weight proteins in an abnormal configuration. In light-chain amyloidosis (AL), monoclonal free lambda (λ) or kappa (κ) light chains are the amyloid proteins involved and
Lynna Alnimer, Ali Zakaria, Jalpa Patel, Yazan Samhouri, Samira Ahsan, Lyle Goldman, Serge Sorser   +6 more
doaj   +1 more source

Monoclonal IgM-related AL amyloidosis

, 2016
Monoclonal immunoglobulin M (IgM)-related light chain (AL) amyloidosis, which accounts for 5%–7% of all AL amyloidosis cases, is a distinct clinical entity that poses specific challenges to clinicians.
Milani P., Merlini G.
core   +1 more source

DNA Nanotechnology Meets Peptide and Protein Self‐Assembly

Chemistry – A European Journal, EarlyView.
Combining DNA nanotechnology with peptide and protein assembly provides complementary platforms for the rational engineering of functional biomaterials. This Perspective discusses the emerging field of self‐assembling DNA‐peptide and DNA‐protein hybrid systems that combine the structural precision and programmability of DNA nanotechnology with the ...
Marcel Hanke, Nanjundan Raghul, Adrian Keller, Veikko Linko, Verónica I. Dodero   +4 more
wiley   +1 more source

Immune checkpoint expression patterns on T cell subsets in light-chain amyloidosis: VISTA, PD-1, and TIGIT as potential therapeutic targets

Blood Science
Amyloid light chain (AL) amyloidosis is a rare plasma cell dyscrasia with dismal prognosis. This study aims to investigate the T-cell immune checkpoint expression patterns in systemic AL amyloidosis and its relationship with clinicobiological traits.
Jinghua Wang, Yujie Zhao, Pengjun Liao, Shuxin Huang, Youxue Huang, Shaohua Chen, Yangqiu Li, Liye Zhong   +7 more
doaj   +1 more source

A First Report of Endoscopic Ultrasound for the Diagnosis of Pancreatic Amyloid Deposition in Immunoglobulin Light Chain (AL) Amyloidosis (Primary Amyloidosis) [PDF]

, 2013
Context Pancreatic involvement in systemic light chain (AL)-amyloidosis is exceedingly rare. Prior reports of endoscopic ultrasound (EUS) for the diagnosis of amyloidosis are also limited.
Weston, Brian R, Bhutani, Manoop S, Mosher, Charles H, Staerkel, Gregg A, Krishna, Somashekar G   +4 more
core   +1 more source

Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis

ESC Heart Failure, Volume 12, Issue 2, Page 809-818, April 2025.
Abstract Aims This study aimed to evaluate the change of the main electrocardiographic (ECG) characteristics and their prognostic role across the main subtypes of cardiac amyloidosis [light‐chain amyloidosis (AL) and hereditary (ATTRv) and wild‐type transthyretin amyloidosis (ATTRwt)].
Alessia Argirò, Mattia Zampieri, Carlotta Mazzoni, Carlo Fumagalli, Michela Baccini, Alessandra Mattei, Alberto Cipriani, Laura De Michieli, Aldostefano Porcari, Gianfranco Sinagra, Marco Merlo, Giacomo Tini, Beatrice Musumeci, Domitilla Russo, Pier Filippo Vianello, Marco Canepa, Roberto Licordari, Gianluca di Bella, Claudio Rapezzi, Federico Perfetto, Francesco Cappelli   +20 more
wiley   +1 more source

Light Chain Cardiac Amyloidosis With Skeletal Muscle Weakness

JACC: Case Reports
Background: Amyloid light chain (AL) amyloidosis can manifest with heterogeneous, multisystem features. Cardiac involvement is common and drives prognosis.
Elyn Montgomery, BN, PhD, Natasha Gorrie, MD, Georgia McCaughan, BMedSc, MBBS, MMed, James Nadel, BA (Adv), MBBS (Hon I), MMed, PhD, Karan Shahi, MSc, N.K. Bart, MD, PhD, Antonia S. Carroll, BSc (Adv), MBBS   +6 more
doaj   +1 more source